Pharma Journalist -

SMi’s 2nd annual Injectable Drug Delivery Conference is returning to London on the 15th and 16th May 2019. SMi Group are delighted to have Dr Joël Richard chairing the two-day…
Read More...

SMi Group Reports: The 7th Annual Conference for Lyophilisation taking place on the 3rd- 4th of June plus a two day interactive workshop on the 5th of June 2019 in London, UK.…
Read More...

Gilead Sciences, Inc. announced findings from two studies that support the further development of GS-6207, a novel, selective, first-in-class inhibitor of HIV-1 capsid function, for…
Read More...

Douglas Cusato from Sumitomo Rubber Industries will be speaking next month at The 6th annual Pre-Filled Syringes East Coast Conference in Boston, where he will discuss the current…
Read More...

Bayer has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for darolutamide for the treatment of patients with non-metastatic…
Read More...

Celgene Corporation announced the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for fedratinib and granted a Priority Review. Fedratinib…
Read More...

Beam Therapeutics announced the successful completion of a $135 million Series B financing. Proceeds from the financing will be used to advance the company’s development of…
Read More...

Domainex is pleased to announce that a team of its scientists, working in close partnership with Professor Michael Schneider and his team at Imperial College, have found a potential new…
Read More...

GTx, Inc. and Oncternal Therapeutics, Inc. jointly announced that they have entered into a definitive merger agreement under which the stockholders of Oncternal would become the…
Read More...

Sartorius Stedim Biotech (SSB) and Novasep based in Pompey, France, have entered into a collaboration agreement in the area of chromatography and single-use bioprocessing. Novasep…
Read More...